Sign Up to like & get
recommendations!
0
Published in 2024 at "ChemMedChem"
DOI: 10.1002/cmdc.202400422
Abstract: Tumor progression depends on angiogenesis, which is stimulated by growth factors like VEGF, targeting VEGFR kinase with small molecules is an effective anti‐angiogenic therapeutic approach. The rational modification of sunitinib (VEGFR‐2 inhibitor) to spirocyclopropyloxindoline carboxamides…
read more here.
Keywords:
iii allosteric;
type iii;
vegfr inhibitors;
vegfr ... See more keywords